"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Older news

PHARMATEST OPENS NEW US SALES OFFICES

July 15, 2016

Pharmatest Services Ltd (Pharmatest) has opened new US sales offices in San Diego, CA, and Concord, MA near Boston. At the same time Pharmatest signed a service agreement with Regus, allowing…

Read More »

Pharmatest Services Ltd attends Tumor Models 2016 Event in Boston

July 5, 2016

Pharmatest Services Ltd attends 4th Annual Tumor Models conference in Boston, MA, on July 19 – 21. Pharmatest is sponsoring the conference and holds a scientific oral presentation and poster…

Read More »

Pharmatest releases series of White Papers in 2016

May 30, 2016

Pharmatest Services Ltd releases three White Papers during 2016. The first White Paper was released before the AACR Annual Meeting on April. The second White Paper will be released before the Hanson…

Read More »

Pharmatest Services Ltd attends AACR Annual Meeting in New Orleans

April 5, 2016

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in New Orleans, LA, USA on April 16 – 20, 2016. Pharmatest attends the event with a booth (#1524)…

Read More »

Pharmatest Services Ltd attends ORS and TRI-CON events

March 4, 2016

Pharmatest Services Ltd attends the ORS Annual Meeting in Orlando, Florida, on March 5 – 8, and the TRI-CON event in San Francisco, California, on March 6 – 11. Pharmatest has scientific poster…

Read More »

The list of events that Pharmatest attends during 2016 has been finalized

January 18, 2016

Pharmatest Services Ltd has finalized the list of events that the company will attend during 2016. The list includes 16 events, of which 3 are attended with a booth. The number of events is…

Read More »

Pharmatest hires new personnel after continuous growth of business

January 11, 2016

After several years of profitable growth Pharmatest will increase its staff amount by hiring four new employees in early 2016. The turnover of Pharmatest increased by 30% in 2015 compared with 2014,…

Read More »

Pharmatest Services Ltd partners with Valirx Plc for GeneICE development

October 28, 2015

Pharmatest Services Ltd and Valirx Plc have signed a 3-year collaboration agreement related to the proprietary GeneICE technology of Valirx. During the project Pharmatest will be responsible for…

Read More »

Pharmatest Services Ltd attends AACR-NCI-EORTC Meeting in Boston

October 19, 2015

Pharmatest Services Ltd attends the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics that will be held in Boston, MA, USA on November 5 – 9, 2015. Pharmatest…

Read More »

Pharmatest Services Ltd received R&D funding from two EU-programs

September 29, 2015

Together with its European partners Pharmatest Services Ltd has received two positive funding decisions for its R&D projects, one from the Eurostars-program and the other from the EuroTransBio…

Read More »

Pharmatest Services Ltd approved for French Research Tax Credit

September 15, 2015

Pharmatest Services Ltd has been approved as an R&D performing organization by French tax authorities. The decision means that French customers of Pharmatest will benefit substantial tax credits…

Read More »

Pharmatest Services Ltd attends ASBMR Annual Meeting in Seattle

September 3, 2015

Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Seattle, WA, USA on October 9 – 12, 2015. Pharmatest has four…

Read More »

Pharmatest Services Ltd participates Tumor Models event in Boston

July 9, 2015

Pharmatest Services Ltd attends Tumor Models event of Hanson Wade held in Boston, MA, USA, on July 21 – 23. Pharmatest has a sponsored talk and three poster presentations in the event, and welcomes…

Read More »

Pharmatest to attend 2015 OARSI World Congress in Seattle

April 28, 2015

Pharmatest will be attending the 2015 Osteoarthritis Research Society International (OARSI) World Congress in Seattle, WA, USA on April 30 - May 3, 2015. Pharmatest attends the congress with a…

Read More »

Pharmatest Services Ltd participates CIBD in Rotterdam

April 24, 2015

Pharmatest Services Ltd attends Cancer-Induced Bone Disease (CIBD) meeting held in parallel with the ECTS-IBMS meeting in Rotterdam, The Netherlands, on April 25 – 28. Pharmatest has three scientific…

Read More »

Pharmatest Services Ltd published new scientific cancer review article

March 26, 2015

Pharmatest Services Ltd has published a new scientific review article “Importance of microenvironment in preclinical models of breast and prostate cancer”. The article was written in collaboration…

Read More »

Pharmatest Services Ltd attends AACR Annual Meeting in Philadelphia

March 24, 2015

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in Philadelphia, PA, USA on April 18 – 22, 2015. Pharmatest attends the event with a booth…

Read More »

The list of events that Pharmatest attends during 2015 has been updated

March 19, 2015

Pharmatest Services Ltd has updated the list of events that the company will attend during 2015. The list includes 11 events, of which 8 are attended with scientific presentations and 3 are attended…

Read More »

Pharmatest Services Ltd attends EAU congress in Madrid

March 16, 2015

Pharmatest Services Ltd attends the European Association of Urology (EAU) congress held in Madrid, Spain on March 20 – 24, 2015. Pharmatest attends the event with two scientific presentations.…

Read More »

Pharmatest Services Ltd attends TRI-CON conference in San Francisco

January 27, 2015

Pharmatest Services Ltd attends Cambridge Healthtech Institute’s third annual conference on “Predictive Preclinical Models in Oncology” that will be held in the Moscone North Convention Center in San…

Read More »

Pharmatest Services at Tumour Models London 2014

November 28, 2014

December 2nd-4th, 2014 Pharmatest will be attending the Tumour Models meeting in London. The number one aim of this year's Tumour Model London meeting is to improve the predictability and…

Read More »

Pharmatest Services Ltd attends EORTC-NCI-AACR symposium in Barcelona

October 27, 2014

Pharmatest Services Ltd attends 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics that will be held in Barcelona, Spain on November 18 – 21, 2014. In the symposium Pharmatest…

Read More »

Pharmatest Services Ltd attends ASBMR Annual Meeting in Houston

August 27, 2014

Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Houston, TX, USA on September 12 – 15, 2014. Pharmatest has three…

Read More »

Pharmatest in Boston at the 13th Annual World Pharma Congress

May 21, 2014

Pharmatest will be attending the 13th Annual World Pharma Congress in Boston, MA, held on May 21-23, 2014. In the event Pharmatest has a poster presentation and an invited oral presentation in the…

Read More »

Pharmatest attended AACR in San Diego

May 2, 2014

Pharmatest Services Ltd had a very successful meeting in the Annual Meeting of American Association for Cancer Research (AACR) in San Diego, CA, USA on April 5 – 9, 2014. Pharmatest attended the event…

Read More »

Pharmatest to attend 2014 OARSI World Congress

April 23, 2014

Pharmatest will be attending the 2014 OARSI World Congress in Paris, France on April 24-27, 2014. Pharmatest attends the congress with a scientific presentation that characterizes the effects of…

Read More »

Pharmatest Services Ltd launches new products in AACR Annual Meeting in San Diego

March 7, 2014

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in San Diego, CA, USA on April 5 – 9, 2014. Pharmatest attends the event with a booth and…

Read More »

Pharmatest to attend Physiologically-Relevant Cellular Models for Drug Discovery meeting

February 14, 2014

Pharmatest to attend High-Content Analysis and Physiologically-Relevant Cellular Models for Drug Discovery meeting on February 19-20, 2014 in San Diego Marriott La Jolla, La Jolla, CA, USA. If you…

Read More »

Pharmatest to attend Predictive Preclinical Models in Oncology meeting

February 5, 2014

Pharmatest will be attending Predictive Preclinical Models in Oncology meeting on February 10-12, 2014 in Moscone North Convention Center, San Francisco, CA, USA. If you would like to meet our…

Read More »

Pharmatest Services Ltd attends CIBD conference in Miami with scientific presentations

October 29, 2013

Pharmatest Services Ltd attends 13th international conference on cancer-induced bone disease (CIBD) held in Miami, FL, USA on November 6 – 9, 2013. In the conference Pharmatest presents scientific…

Read More »

Pharmatest Services Ltd launches new preclinical osteoarthritis models

September 13, 2013

[Updated October 4, 2013] Turku, Finland -based CRO Pharmatest Services Ltd launches new fully validated preclinical efficacy models for osteoarthritis that were developed in a Eurostars-funded…

Read More »

Bayer credits high quality of Pharmatest after joint publication of results for their FDA approved new cancer drug Xofigo

May 22, 2013

Pharmatest Services Ltd (Pharmatest) has been the preferred provider of Bayer Pharma AG (Bayer) since 2010. The results of several projects performed at Pharmatest regarding the newly FDA approved…

Read More »

Pharmatest to present new data at the OARSI 2013 Meeting

April 11, 2013

[Updated April 18, 2013] Pharmatest is proud to inform development of four new rat osteoarthritis models that will be soon available as service products. The new models will be presented for the first…

Read More »

Pharmatest to exhibit and present new data at the AACR 2013 Meeting

March 20, 2013

[Updated April 9, 2013] Pharmatest will be attending the key annual event in cancer research, AACR Annual Meeting in Washington DC, USA, April 6-10. Come and meet us at our exhibit booth (#907) -…

Read More »

Pharmatest Services Ltd opens US sales office in Cambridge, MA

February 22, 2013

[Updated March 21, 2013] Turku, Finland-based Pharmatest Services Ltd (Pharmatest) has opened a new US sales office in Cambridge, MA near Boston. The new office provides an excellent opportunity for…

Read More »

Pharmatest to present novel compound data at the CIBD Meeting 2012

Pharmatest became preferred provider of Valirx

October 16, 2012

The Turku-based company Pharmatest Services Ltd (Pharmatest) has signed a Master Service Agreement with the London AIM-listed cancer drug development company Valirx Plc (Valirx). The agreement makes…

Read More »